Severe insulin resistance due to insulin antibodies

被引:4
作者
Xiao, Yang [1 ,2 ]
Li, Xia [1 ,2 ]
Chao, Chen [1 ,2 ]
Huang, Gan [1 ,2 ]
Tang, Weili [1 ,2 ]
Liu, Shiping [1 ,2 ]
Xie, Zhiguo [1 ,2 ]
Zhou, Zhiguang [1 ,2 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China
[2] Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
LISPRO;
D O I
10.1111/1753-0407.12657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:611 / 613
页数:3
相关论文
共 50 条
  • [31] Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
    Hemkens, L. G.
    Grouven, U.
    Bender, R.
    Guenster, C.
    Gutschmidt, S.
    Selke, G. W.
    Sawicki, P. T.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1732 - 1744
  • [32] Successful treatment with continuous subcutaneous insulin infusion for allergy to human insulin and its analogs
    Zhang, Lin
    Zhang, Mei
    Liu, Yuan Yuan
    Hu, Maoqing
    Zhou, Xuelei
    Luo, Yu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (01) : E1 - E2
  • [33] Faster In and Faster Out: Accelerating Insulin Absorption and Action by Insulin Infusion Site Warming
    Cengiz, Eda
    Weinzimer, Stuart A.
    Sherr, Jennifer L.
    Tichy, Eileen M.
    Carria, Lori
    Cappiello, Darryll
    Steffen, Amy
    Tamborlane, William V.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (01) : 20 - 25
  • [34] Insulin receptor-insulin interaction kinetics using multiplex surface plasmon resonance
    Subramanian, Kannan
    Fee, Conan J.
    Fredericks, Rayleen
    Stubbs, Richard S.
    Hayes, Mark T.
    [J]. JOURNAL OF MOLECULAR RECOGNITION, 2013, 26 (12) : 643 - 652
  • [35] Insulin Glulisine Has a Faster Onset of Action Compared with Insulin Aspart in Healthy Volunteers
    Arnolds, S.
    Rave, K.
    Hoevelmann, U.
    Fischer, A.
    Sert-Langeron, C.
    Heise, T.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (09) : 662 - 664
  • [36] Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
    L. G. Hemkens
    U. Grouven
    R. Bender
    C. Günster
    S. Gutschmidt
    G. W. Selke
    P. T. Sawicki
    [J]. Diabetologia, 2009, 52 : 1732 - 1744
  • [37] Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes
    Hattori, Naoki
    Duhita, Maharani Retna
    Mukai, Akira
    Matsueda, Megumi
    Shimatsu, Akira
    [J]. CLINICA CHIMICA ACTA, 2014, 433 : 135 - 138
  • [38] Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial
    Niskanen, Leo
    Leiter, Lawrence A.
    Franek, Edward
    Weng, Jianping
    Damci, Taner
    Munoz-Torres, Manuel
    Donnet, Jean-Paul
    Endahl, Lars
    Skjoth, Trine Vang
    Vaag, Allan
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (02) : 287 - 294
  • [39] Comment on the Insulin Table 2022
    Duefer, Martina
    Duefer-Kinzinger, Alexandra
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2022, 31 (06): : 393 - 394
  • [40] The use of insulin analogues in pregnancy
    Lambert, K.
    Holt, R. I. G.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (10) : 888 - 900